5-Methyl-3-[1-(4-methylphenyl)-1H-pyrazol-5-yl]-N-(1,3-thiazol-2-yl)-1,2-oxazole-4-carboxamide

Catalog No. :
ACPIPP687
CAS No. :
318959-10-3
Molecular Formula :
C18H15N5O2S
Molecular Weight :
365.42

IUPAC Name:5-methyl-N-(thiazol-2-yl)-3-(1-(p-tolyl)-1H-pyrazol-5-yl)isoxazole-4-carboxamide

5-Methyl-3-[1-(4-methylphenyl)-1H-pyrazol-5-yl]-N-(1,3-thiazol-2-yl)-1,2-oxazole-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methyl-3-[1-(4-methylphenyl)-1H-pyrazol-5-yl]-N-(1,3-thiazol-2-yl)-1,2-oxazole-4-carboxamide
IUPAC Name5-methyl-N-(thiazol-2-yl)-3-(1-(p-tolyl)-1H-pyrazol-5-yl)isoxazole-4-carboxamide
MDL No.MFCD00664787
Molecular FormulaC18H15N5O2S
Molecular Weight365.42
SMILESO=C(C1=C(C)ON=C1C2=CC=NN2C3=CC=C(C)C=C3)NC4=NC=CS4
InChI KeyASWMAOMSLSESCL-UHFFFAOYSA-N
Synonym5-METHYL-3-[1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N-(1,3-THIAZOL-2-YL)-4-ISOXAZOLECARBOXAMIDE;5-methyl-3-[1-(4-methylphenyl)-1H-pyrazol-5-yl]-N-(1,3-thiazol-2-yl)-1,2-oxazole-4-carboxamide;4-Isoxazolecarboxamide, 5-methyl-3-[1-(4-methylphenyl)-1H-pyrazol-5-yl]-N-2-thiazolyl-
CAS No.318959-10-3

Synthetic Route by SureRoute

1. ACPIPP687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8 In Stock
  4. Then
  5. ACPIPP687 route product structure diagram
    ACPIPP687318959-10-3
Inquiry

2. ACPIPP687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8 In Stock
  4. Then
  5. ACPIPP687 route product structure diagram
    ACPIPP687318959-10-3
Inquiry

Comments (0)